135 related articles for article (PubMed ID: 35932567)
1. An auristatin-based peptide-drug conjugate targeting Kita-Kyushu lung cancer antigen 1 for precision chemoradiotherapy in gastric cancer.
Chen X; Liu F; Yu X; Li L; Yan J; Chen X; Liu Q; Liu B
Eur J Med Chem; 2022 Nov; 241():114617. PubMed ID: 35932567
[TBL] [Abstract][Full Text] [Related]
2. Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability.
Hingorani DV; Doan MK; Camargo MF; Aguilera J; Song SM; Pizzo D; Scanderbeg DJ; Cohen EEW; Lowy AM; Adams SR; Advani SJ
Mol Cancer Ther; 2020 Jan; 19(1):157-167. PubMed ID: 31597712
[TBL] [Abstract][Full Text] [Related]
3. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
[TBL] [Abstract][Full Text] [Related]
4. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
Buckel L; Savariar EN; Crisp JL; Jones KA; Hicks AM; Scanderbeg DJ; Nguyen QT; Sicklick JK; Lowy AM; Tsien RY; Advani SJ
Cancer Res; 2015 Apr; 75(7):1376-1387. PubMed ID: 25681274
[TBL] [Abstract][Full Text] [Related]
5. Expression of Kita-Kyushu Lung Cancer Antigen-1 as Detected by a Novel Monoclonal Antibody in Gastric Cancer.
Takahashi Y; Fukuyama T; Futawatari N; Ichiki Y; Ohmiya H; Chuman M; Yamashita T; Hiki N; Kumamoto Y; Yamazaki H; Nonoguchi H; Nishi Y; Kobayashi N
Anticancer Res; 2019 Nov; 39(11):6259-6263. PubMed ID: 31704855
[TBL] [Abstract][Full Text] [Related]
6. Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1.
Marcinkowski B; Stevanović S; Helman SR; Norberg SM; Serna C; Jin B; Gkitsas N; Kadakia T; Warner A; Davis JL; Rooper L; Hinrichs CS
J Immunother Cancer; 2019 Aug; 7(1):229. PubMed ID: 31455429
[TBL] [Abstract][Full Text] [Related]
7. Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.
Luo D; Wang X; Walker E; Springer S; Ramamurthy G; Burda C; Basilion JP
ACS Appl Mater Interfaces; 2022 Apr; 14(13):14916-14927. PubMed ID: 35316026
[TBL] [Abstract][Full Text] [Related]
8. Identification of a peptide binding to cancer antigen Kita-kyushu lung cancer antigen 1 from a phage-display library.
Yu X; Yan J; Chen X; Wei J; Yu L; Liu F; Li L; Liu B
Cancer Sci; 2021 Oct; 112(10):4335-4345. PubMed ID: 34387029
[TBL] [Abstract][Full Text] [Related]
9. An auristatin-based antibody-drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer.
Bourillon L; Bourgier C; Gaborit N; Garambois V; Llès E; Zampieri A; Ogier C; Jarlier M; Radosevic-Robin N; Orsetti B; Delpech H; Theillet C; Colombo PE; Azria D; Pèlegrin A; Larbouret C; Chardès T
Int J Cancer; 2019 Oct; 145(7):1838-1851. PubMed ID: 30882895
[TBL] [Abstract][Full Text] [Related]
10. Cancer/testis antigen, Kita-Kyushu lung cancer antigen-1 and ABCD stratification for diagnosing gastric cancers.
Shida A; Fukuyama T; Futawatari N; Ohmiya H; Ichiki Y; Yamashita T; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M; Takahashi Y
World J Gastroenterol; 2020 Jan; 26(4):424-432. PubMed ID: 32063691
[TBL] [Abstract][Full Text] [Related]
11. Preparation and anti-cancer evaluation of promiximab-MMAE, an anti-CD56 antibody drug conjugate, in small cell lung cancer cell line xenograft models.
Yu L; Yao Y; Wang Y; Zhou S; Lai Q; Lu Y; Liu Y; Zhang R; Wang R; Liu C; Gou L; Chen X; Yu Y; Chen Q; Yang J
J Drug Target; 2018 Dec; 26(10):905-912. PubMed ID: 29630426
[TBL] [Abstract][Full Text] [Related]
12. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
[TBL] [Abstract][Full Text] [Related]
13. A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.
Yu SF; Zheng B; Go M; Lau J; Spencer S; Raab H; Soriano R; Jhunjhunwala S; Cohen R; Caruso M; Polakis P; Flygare J; Polson AG
Clin Cancer Res; 2015 Jul; 21(14):3298-306. PubMed ID: 25840969
[TBL] [Abstract][Full Text] [Related]
14. An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer.
Pan D; Tang Y; Tong J; Xie C; Chen J; Feng C; Hwu P; Huang W; Zhou D
Cancer Med; 2020 Dec; 9(24):9529-9540. PubMed ID: 33084221
[TBL] [Abstract][Full Text] [Related]
15. Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.
Kuo WY; Hsu HJ; Wu CY; Chen HS; Chou YC; Tsou YL; Peng HP; Jian JW; Yu CM; Chiu YK; Chen IC; Tung CP; Hsiao M; Lin CL; Wang YA; Wang AH; Yang AS
MAbs; 2019 Jan; 11(1):153-165. PubMed ID: 30365359
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Expression of the Cancer/Testis Antigen KK-LC-1 and
Fukuyama T; Futawatari N; Ichiki Y; Shida A; Yamazaki T; Nishi Y; Nonoguchi H; Takahashi Y; Yamazaki H; Kobayashi N
In Vivo; 2017; 31(3):403-407. PubMed ID: 28438869
[TBL] [Abstract][Full Text] [Related]
17. Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer.
Li Z; Wang M; Yu D; Luo W; Fang J; Huang C; Yao X
Cancer Chemother Pharmacol; 2019 Jul; 84(1):61-72. PubMed ID: 31037333
[TBL] [Abstract][Full Text] [Related]
18. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
[TBL] [Abstract][Full Text] [Related]
19. Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).
Yaghoubi S; Gharibi T; Karimi MH; Sadeqi Nezhad M; Seifalian A; Tavakkol R; Bagheri N; Dezhkam A; Abdollahpour-Alitappeh M
Breast Cancer; 2021 Jan; 28(1):216-225. PubMed ID: 32889587
[TBL] [Abstract][Full Text] [Related]
20. A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells.
Serwotka-Suszczak AM; Sochaj-Gregorczyk AM; Pieczykolan J; Krowarsch D; Jelen F; Otlewski J
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
